Founded in 2015 in California, NeuroVasc Technologies brings over 100 years of combined expertise in neurovascular device design and development. NeuroVasc is focused on developing a portfolio of novel catheter-based technologies to facilitate broad treatment options for patients suffering stroke and other neurological conditions. Through Integrity, Collaboration, Passion, and continued Innovation, we are committed to Delivering Excellence as a dynamic creator of neurovascular devices.


Q3, 2015
  • NeuroVasc Founded
Q3, 2017
  • CE Mark Versi System
  • Japan First in Human study enrollment
Q1, 2019
  • CE mark eNVi-SR
  • Wego Group Strategic Partnership
Q4, 2019
  • Japan PI Study first enrollment
  • Irvine Facility Qualification
Q2, 2020
  • eNVoke Catheters CE Mark
Q3, 2020
  • Japan PI Study last enrollment
Q1, 2021
  • eNVac Aspiration Catheter CE Mark
Q3, 2021
  • China eNVi™-SR Randomized Controlled Trial first enrollment
Q4, 2021
  • Expansion to Worldwide Commercial Activities
Q2, 2022
  • US IDE (ENVI RCT) first enrollment (planned)
accomplishments-img-1 accomplishments-img-2